final results of the aim study of ibrutinib and venetoclax in mantle cell lymphoma
Published 7 years ago • 227 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
2:00
preliminary results of the aim trial of ibrutinib and venetoclax in mantle cell lymphoma
-
1:34
the success of ibrutinib in treating mantle cell lymphoma (mcl)
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
3:06
durable responses to ibrutinib and venetoclax in r/r mcl: 3-year aim update
-
5:50
venetoclax and r2 in mantle cell lymphoma
-
1:00
ash 2022 lba: results from final analysis of alpine - zanubrutinib vs ibrutinib for r/r cll/sll
-
23:23
identifying and treating high-risk patients in 2023
-
1:03:27
[online seminar] new holladay report for best results in iol calculations & refractive surgery
-
1:55
piccolo xpress with capillary tube
-
1:35
long-term ibrutinib outcomes vs. prior regimens: pooled analysis in r/r mcl
-
0:26
acalabrutinib plus venetoclax and rituximab in the treatment of mcl
-
4:01
ibrutinib vs temsirolimus in relapsed/refractory mantle cell lymphoma
-
1:43
results from a phase ii trial of pirtobrutinib, venetoclax, and obinutuzumab in cll
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
15:32
panel discussion on mantle cell lymphoma
-
2:12
results from a phase i trial of tinostamustine in patients with r/r classical hl
-
1:38
phase ii study of epcoritamab in r/r lbcl
-
2:19
anbal-cel: updated results from phase i study of novel cd19-targeting car-t therapy
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
1:35
update on phase i study of plamotamab in r/r nhl